Sayed C, Shi V, Hsiao J, Kokolakis G, Kirby B, Piguet V, Davis L, Bari M, Madden C, Knowles S, Prens E. Bimekizumab Efficacy by Prior Biologic Treatment in Patients with Moderate to Severe Hidradenitis Suppurativa: 48-Week Pooled Data from the Randomized, Double-Blind, Placebo-Controlled, Multicenter BE HEARD I and II Phase 3 Trials. J of Skin [Internet]. 2024Jan.16 [cited 2024Jul.3];8(1):s349. Available from: https://jofskin.org/index.php/skin/article/view/2449